# New Mexico — State drug price transparency reporting thresholds, triggers, and penalties for pharmaceutical manufacturers

For New Mexico, new drug wac threshold is $400 for a 30-day supply; price increase % trigger is 10% in the previous calendar year or 16% over the previous two calendar years; reporting deadline is first reporting deadline June 1, 2025; generic/biosimilar trigger is 30% or more over the previous calendar year; statute is NM HB 33, recorded from its source on 2026-08-14.

- **State:** New Mexico
- **New drug WAC threshold:** $400 for a 30-day supply
- **Price increase % trigger:** 10% in the previous calendar year or 16% over the previous two calendar years _(verified: appears in the quote below)_
- **Reporting deadline:** first reporting deadline June 1, 2025
- **Generic/biosimilar trigger:** 30% or more over the previous calendar year _(verified: appears in the quote below)_
- **Statute:** NM HB 33 _(verified: appears in the quote below)_

## What the source says

> NM HB 33 requires drug manufacturers to report to the state data for any (1) drugs with a WAC of $400 or more for a 30-day supply, (2) course of treatment that is shorter than 30 days for a brand-name drug that has increased in WAC by 10% or more in the previous calendar year or by 16% or more over the course of the previous two calendar years, or (3) a generic drug or biosimilar that has increased in WAC by 30% or more over the previous calendar year.

## Source

- https://www.goodwinlaw.com/en/insights/publications/2025/06/alerts-lifesciences-state-drug-transparency-laws

Last verified: 2026-08-14. Review by: 2027-02-10.
Part of [State drug price transparency reporting thresholds, triggers, and penalties for pharmaceutical manufacturers](https://referencesource.org/drug-price-transparency-thresholds/).